GO:0005334 norepinephrine:sodium symporter activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0005334 describes the molecular function that couples norepinephrine reuptake to the inward transport of sodium and chloride ions across a membrane.
• The human noradrenaline transporter (NET, gene SLC6A2) is the principal protein that carries out this activity in the nervous system.
• Cryo-EM structures of human NET have revealed the binding sites for norepinephrine, sodium, chloride, and clinically used inhibitors.
• This transport activity is essential for terminating noradrenergic neurotransmission and for regulating blood pressure and sodium homeostasis.
• Dysregulation of norepinephrine:sodium symporter activity is implicated in hypertension, heart failure, and neuropsychiatric disorders.
• CRISPR-based knockout, point-mutation, and knock-in models enable precise dissection of SLC6A2 function and its disease relevance.
Description
GO:0005334, norepinephrine:sodium symporter activity, is a molecular function that enables the transfer of norepinephrine across a membrane together with sodium and chloride ions. This activity is fundamental to the termination of noradrenergic signaling in the central and peripheral nervous systems, and it is a target of widely prescribed antidepressants and cardiovascular drugs. Researchers study this term to understand how neurotransmitter clearance is achieved at the molecular level and how its dysfunction contributes to disease.
norepinephrine:sodium symporter activity At A Glance
| GO ID | GO:0005334 |
|---|---|
| GO term | norepinephrine:sodium symporter activity |
| Ontology | molecular_function |
| Synonym | noradrenaline transporter activity; norepinephrine:sodium:chloride symporter activity; levarterenol transporter activity |
| Major function | Sodium- and chloride-coupled reuptake of norepinephrine across the plasma membrane |
| Major protein | SLC6A2 (NET, noradrenaline transporter) |
| Ion coupling | Na+ and Cl- are co-transported with norepinephrine |
| Inhibitors | Antidepressants and psychostimulants block this activity |
What Is GO:0005334?
According to the Gene Ontology, GO:0005334 enables the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: norepinephrine(out) + Na+(out) + Cl-(out) = norepinephrine(in) + Na+(in) + Cl-(in). In other words, it is the sodium- and chloride-dependent transport activity that moves norepinephrine into a cell.
Why Is norepinephrine:sodium symporter activity Important in Cell Biology?
Norepinephrine:sodium symporter activity is critical for maintaining normal noradrenergic neurotransmission and systemic sodium balance. Its dysfunction is linked to salt-sensitive hypertension, heart failure, and mood disorders, making it a key target for drug development and a focus of structural and functional studies.
• Terminates noradrenergic signaling by clearing norepinephrine from the synaptic cleft.
• Regulates blood pressure and sodium homeostasis, with implications for salt-sensitive hypertension.
• Is the molecular target of tricyclic antidepressants, selective serotonin-norepinephrine reuptake inhibitors, and psychostimulants.
• Contributes to cardiovascular control and is studied in heart failure models.
• Its structural mechanism has been resolved by cryo-EM, guiding rational drug design.
• Genetic variants in SLC6A2 are associated with neuropsychiatric and autonomic disorders.
• Provides a paradigm for understanding neurotransmitter:sodium symporter (NSS) family dynamics.
• Serves as a model for ion-coupled transport in lipid bilayers.
What Happens During norepinephrine:sodium symporter activity?
Substrate binding and ion coupling
In simple terms: The transporter grabs norepinephrine along with sodium and chloride ions from outside the cell.
The reaction requires the binding of one norepinephrine molecule together with Na+ and Cl- ions to the transporter. Structural studies of human NET show that these substrates occupy distinct but coupled binding sites within the transporter's central cavity.
Conformational transition and translocation
In simple terms: The transporter changes shape to move the bound molecules across the membrane.
Upon binding, the transporter undergoes a conformational change from an outward-facing to an inward-facing state, releasing norepinephrine and ions into the cytoplasm. Molecular dynamics simulations in lipid bilayers have detailed these transitions for a related neurotransmitter:sodium symporter.
Inhibition by antidepressants
In simple terms: Drugs can block the transporter, keeping norepinephrine outside the cell.
Cryo-EM structures of human NET bound to inhibitors such as nortriptyline and nisoxetine reveal how these compounds stabilize the outward-facing state and prevent reuptake. This mechanism underlies the therapeutic action of many antidepressants.
Key Genes Involved in GO:0005334 norepinephrine:sodium symporter activity
The following genes and proteins are directly or indirectly involved in norepinephrine:sodium symporter activity and its regulation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC6A2 | Encodes the noradrenaline transporter (NET) that carries out GO:0005334 | Primary target for structural and pharmacological studies |
| SLC6A3 | Dopamine transporter, closely related NSS family member | Comparative studies of ion-coupled transport |
| SLC6A4 | Serotonin transporter, related NSS family member | Model for understanding NSS dynamics |
| ATP1A1 | Na+/K+-ATPase subunit that maintains sodium gradient | Provides driving force for sodium-coupled transport |
| ATP1A2 | Na+/K+-ATPase subunit | Sodium homeostasis in muscle and neurons |
| ADRB1 | Beta-1 adrenergic receptor, downstream of norepinephrine | Adrenergic control of sodium-potassium homeostasis |
| ADRB2 | Beta-2 adrenergic receptor | Modulates Na+/K+ pump activity |
| SLC12A3 | Sodium chloride cotransporter in kidney | Linked to salt-sensitive hypertension |
| WNK1 | Regulates sodium chloride cotransporter | Implicated in hypertension |
| WNK4 | Regulates sodium chloride cotransporter | Implicated in hypertension |
| SCN1A | Voltage-gated sodium channel | Target of conotoxins, related to ion transport |
| CHRNA3 | Nicotinic acetylcholine receptor subunit | Conotoxin target, ion channel |
| CHRNB4 | Nicotinic acetylcholine receptor subunit | Conotoxin target |
| CACNA1B | Voltage-gated calcium channel | Conotoxin target |
| SLC6A2 variants | Polymorphisms affecting transport activity | Pharmacogenetics of antidepressants |
| GNB3 | G protein subunit beta 3 | Adrenergic signaling |
How Is norepinephrine:sodium symporter activity Regulated?
The activity of the norepinephrine:sodium symporter is regulated by the sodium gradient maintained by the Na+/K+-ATPase. Adrenergic stimulation can modulate Na+/K+ pump activity, indirectly affecting sodium-coupled transport. Additionally, the transporter's function is influenced by its lipid environment and conformational dynamics.
norepinephrine:sodium symporter activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC6A2 | Depression, ADHD, orthostatic intolerance | Knockout mouse, point-mutation knock-in |
| SLC12A3 | Salt-sensitive hypertension | Rat model with impaired NCC activity |
| ATP1A1 | Hypertension, muscle disorders | Muscle-specific knockout |
| ADRB1 | Heart failure, hypertension | Overexpression mouse model |
| SLC6A2 | Drug response variability | Humanized knock-in mice |
Salt-sensitive hypertension
Impaired renal sodium chloride cotransporter activity in the presence of norepinephrine-evoked responses contributes to salt-sensitive hypertension in animal models. This highlights the interplay between adrenergic signaling and sodium transport in blood pressure regulation.
Heart failure
Loop diuretics, which affect sodium handling, are used in chronic heart failure, and their therapeutic effects may relate to modulation of sodium transport pathways. Norepinephrine:sodium symporter activity in the heart and kidney can influence fluid balance and cardiac load.
Neuropsychiatric disorders
The noradrenaline transporter is a target for antidepressants, and its dysfunction is implicated in depression and anxiety. Structural insights into inhibitor binding are guiding the development of new therapeutics.
From norepinephrine:sodium symporter activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does SLC6A2 loss alter norepinephrine clearance? | SLC6A2 knockout mouse or cell line |
| How do point mutations affect transport kinetics? | Point-mutation knock-in via CRISPR |
| Can tagged NET be used for imaging? | Knock-in of fluorescent tag at SLC6A2 locus |
| Does overexpression of NET change sodium homeostasis? | Transgenic overexpression model |
| Which genes modify salt-sensitive hypertension? | CRISPR library screening in renal cells |
| How do antidepressants bind to NET? | Structural studies with purified protein |
How to Study the norepinephrine:sodium symporter activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Cryo-EM | 3D structure of transporter-inhibitor complexes | Drug design and mechanism |
| Radioligand uptake | Norepinephrine transport rate | Kinetic analysis of mutants |
| Molecular dynamics | Conformational transitions | Simulation of transport cycle |
| Patch-clamp | Ion currents coupled to transport | Electrophysiology of NSS |
| Site-directed mutagenesis | Role of specific residues | Structure-function studies |
| CRISPR knockout | Loss-of-function phenotype | Gene function validation |
| RNA-seq | Expression changes after knockout | Transcriptomic profiling |
| Proteomics | Protein interactions and modifications | Identifying regulatory partners |
Structural biology (cryo-EM)
Cryo-EM has been used to determine the structures of human NET in complex with norepinephrine and inhibitors, revealing the molecular basis of transport and inhibition.
Molecular dynamics simulations
Simulations in lipid bilayers have elucidated the conformational dynamics of neurotransmitter:sodium symporters, providing insights into the transport cycle.
Transport assays
Radiolabeled norepinephrine uptake assays in cells expressing wild-type or mutant transporters measure the activity and kinetics of GO:0005334.
Electrophysiology
Patch-clamp and voltage-clamp techniques can measure the currents associated with sodium-coupled transport, as studied for related ion channels and transporters.
How CRISPR Can Be Used to Study GO:0005334 norepinephrine:sodium symporter activity
Knockout
CRISPR knockout of SLC6A2 can abolish norepinephrine:sodium symporter activity, allowing researchers to study the consequences for neurotransmitter clearance and behavior.
Point Mutation
Introducing point mutations in SLC6A2 that mimic human variants can reveal how specific residues affect ion coupling and inhibitor sensitivity.
Knock-in
Knock-in of epitope tags or fluorescent proteins at the endogenous SLC6A2 locus enables real-time imaging and proteomic analysis of the transporter.
Overexpression
Overexpression of SLC6A2 in cell lines or transgenic animals can model enhanced norepinephrine reuptake and its effects on sodium homeostasis.
How EDITGENE Supports norepinephrine:sodium symporter activity Research
Researchers studying norepinephrine:sodium symporter activity-related genes often need to determine whether a candidate gene is causally involved in transport, regulation, or disease. EDITGENE provides comprehensive CRISPR-based services to create precise cellular and animal models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for norepinephrine:sodium symporter activity research.
Frequently Asked Questions About norepinephrine:sodium symporter activity
What is norepinephrine:sodium symporter activity?
It is a molecular function (GO:0005334) that transports norepinephrine across a membrane together with sodium and chloride ions.
What genes are involved in norepinephrine:sodium symporter activity?
The primary gene is SLC6A2, which encodes the noradrenaline transporter (NET). Other genes such as ATP1A1 and ADRB1 regulate the sodium gradient and adrenergic signaling.
Which protein carries out norepinephrine:sodium symporter activity?
The human noradrenaline transporter (NET), encoded by SLC6A2, is the main protein responsible for this activity.
How is norepinephrine:sodium symporter activity regulated?
It is regulated by the sodium gradient maintained by Na+/K+-ATPase and by adrenergic stimulation.
What diseases are associated with norepinephrine:sodium symporter activity?
Dysfunction is linked to salt-sensitive hypertension, heart failure, and neuropsychiatric disorders such as depression.
What drugs target norepinephrine:sodium symporter activity?
Antidepressants like nortriptyline and psychostimulants inhibit the transporter.
How can I study norepinephrine:sodium symporter activity in the lab?
Common methods include radioligand uptake assays, cryo-EM, molecular dynamics simulations, and CRISPR-based gene editing.
What is the role of sodium in norepinephrine transport?
Sodium is co-transported with norepinephrine and provides the driving force for the transport cycle.
Can CRISPR be used to study norepinephrine:sodium symporter activity?
Yes, CRISPR knockout, point mutation, and knock-in models allow precise dissection of SLC6A2 function.
What are the synonyms for norepinephrine:sodium symporter activity?
Synonyms include noradrenaline transporter activity, norepinephrine:sodium:chloride symporter activity, and levarterenol transporter activity.
Conclusion
GO:0005334, norepinephrine:sodium symporter activity, is a fundamental molecular function that controls norepinephrine clearance and sodium homeostasis. Structural and functional studies have illuminated its mechanism and pharmacology, and CRISPR-based models continue to advance our understanding of its role in health and disease.
References
- 1. Hu T et al.. 2024. Transport and inhibition mechanisms of the human noradrenaline transporter.. Nature 632(8026):930-937 PMID: 39085602
- 2. Tan J et al.. 2024. Molecular basis of human noradrenaline transporter reuptake and inhibition.. Nature 632(8026):921-929 PMID: 39048818
- 3. Walsh KR et al.. 2016. Norepinephrine-evoked salt-sensitive hypertension requires impaired renal sodium chloride cotransporter activity in Sprague-Dawley rats.. Am J Physiol Regul Integr Comp Physiol 310(2):R115-24 PMID: 26608659
- 4. Miyata M et al.. 2012. Comparative study of therapeutic effects of short- and long-acting loop diuretics in outpatients with chronic heart failure (COLD-CHF).. J Cardiol 59(3):352-8 PMID: 22365947
- 5. Lewis RJ. 2009. Conotoxins: molecular and therapeutic targets.. Prog Mol Subcell Biol 46:45-65 PMID: 19184584
- 6. Pirkmajer S et al.. 2016. Na,K-ATPase regulation in skeletal muscle.. Am J Physiol Endocrinol Metab 311(1):E1-E31 PMID: 27166285
- 7. Clausen T. 1983. Adrenergic control of Na+-K+-homoeostasis.. Acta Med Scand Suppl 672:111-5 PMID: 6138927
- 8. Adhikary S et al.. 2017. Conformational dynamics of a neurotransmitter:sodium symporter in a lipid bilayer.. Proc Natl Acad Sci U S A 114(10):E1786-E1795 PMID: 28223522
